| 33.91 Delayed Data As of 1:28pm ET |  +1.41 / +4.34%Today’s Change | 15.15 Today|||52-Week Range 38.44 | +46.04% Year-to-Date |
| Previous close | 32.50 |
| Today’s open | 32.42 |
| Day’s range | 32.08 - 34.08 |
| Volume | 74,484 |
| Average volume (3 months) | 193,144 |
| Market cap | $2.2B |
| Earnings growth (last year) | -13.45% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 9,445.18 |
| Price/Book | 7.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| XLRNAcceleron Pharma Inc | +1.22 | +3.09% |
| TLRYTilray Inc | +0.07 | +0.33% |
| IOVAIovance Biotherapeut... | +0.03 | +0.16% |
| CRSPCRISPR Therapeutics ... | -0.08 | -0.20% |
| Next reporting date | November 27, 2019 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $129.3K |
| Annual profit (last year) | -$139.0M |
| Net profit margin | -107,433.56% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Ying Samantha Du |
President, Chief Operating Officer & Director Tao Fu |
Corporate headquarters Shanghai, Shanghai |
